The BMA and the DDA have already been in contact with NHS England following a letter to all heads of primary care in England about the Falsified Medicines Directive.
Contrary to previous discussions this states that dispensing doctors will need to make their own provision [for implementing the FMD] as part of dispensing.
The DDA and the BMA believe this to be an incorrect position, and will be seeking clarification.
The NHS England letter states that work has been progressing with system suppliers to provide an FMD solution as part of their package to practices – thereby signalling that practices do not need to take immediate action.
DDA advice remains that practices in England and Wales should NOT invest in FMD equipment at this point. They can, however, show compliance with the FMD, which came into effect on Saturday 9 February, by registering with SecurMed and by familiarising practice staff with all FMD resources including DDA SOPs.
The letter also states that in an event of a No Deal for Brexit the FMD requirements would be removed from law. Whilst mandated to continue preparations, these need to continue with appropriate caution given the possibility of a No Deal scenario.